DONG QUN CHEN: Open Payments
NPI 1578234654 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 36 payments from 13 companies in 2025. Trend: 2023 $646 · 2024 $638 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $169 |
| Merck Sharp & Dohme LLC | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Exact Sciences Corporation | 2 | $49 |
| Agios Pharmaceuticals, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| PFIZER INC. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Philips North America LLC | 2 | $40 |
Products named: TRELEGY ELLIPTA, TRINTELLIX, VERQUVO, Auvelity, Cologuard Collection Kit, PYRUKYND, BREZTRI, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
